Ultragenyx's gene therapy for rare metabolic disorder secures US FDA nod
RARE•FDA approves Ultragenyx gene therapy
The U.S. Food and Drug Administration approved Ultragenyx Pharmaceutical's gene therapy to treat a rare metabolic disorder, the company said on Wednesday.
